Desvenlafaxine fumarate

富马酸酯去甲文拉法辛

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDesvenlafaxine fumarate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, MajorDepressionSleep Initiation and Maintenance Disorders
Global Approved IndicationsDepressive Disorder, Major
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2013/10/11
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesTeva Pharmaceuticals Usa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford UniversityPfizer IncTeva Pharmaceuticals Usa Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorDepressionSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN06AX23
Related LinksWikipediaDrugBankKEGG